Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 251

1.

An open trial of valproate in borderline personality disorder.

Stein DJ, Simeon D, Frenkel M, Islam MN, Hollander E.

J Clin Psychiatry. 1995 Nov;56(11):506-10.

PMID:
7592502
[PubMed - indexed for MEDLINE]
2.

A preliminary double-blind, placebo-controlled trial of divalproex sodium in borderline personality disorder.

Hollander E, Allen A, Lopez RP, Bienstock CA, Grossman R, Siever LJ, Merkatz L, Stein DJ.

J Clin Psychiatry. 2001 Mar;62(3):199-203.

PMID:
11305707
[PubMed - indexed for MEDLINE]
3.

Efficacy and tolerability of quetiapine in the treatment of borderline personality disorder: A pilot study.

Bellino S, Paradiso E, Bogetto F.

J Clin Psychiatry. 2006 Jul;67(7):1042-6.

PMID:
16889446
[PubMed - indexed for MEDLINE]
4.

Divalproex sodium for impulsive aggressive behavior in patients with personality disorder.

Kavoussi RJ, Coccaro EF.

J Clin Psychiatry. 1998 Dec;59(12):676-80.

PMID:
9921702
[PubMed - indexed for MEDLINE]
5.

An open-label trial of divalproex extended-release in the treatment of borderline personality disorder.

Simeon D, Baker B, Chaplin W, Braun A, Hollander E.

CNS Spectr. 2007 Jun;12(6):439-43.

PMID:
17545954
[PubMed - indexed for MEDLINE]
6.

Impact of trait impulsivity and state aggression on divalproex versus placebo response in borderline personality disorder.

Hollander E, Swann AC, Coccaro EF, Jiang P, Smith TB.

Am J Psychiatry. 2005 Mar;162(3):621-4.

PMID:
15741486
[PubMed - indexed for MEDLINE]
7.

Open-label study of atypical neuroleptic quetiapine for treatment of borderline personality disorder: impulsivity as main target.

Villeneuve E, Lemelin S.

J Clin Psychiatry. 2005 Oct;66(10):1298-303.

PMID:
16259544
[PubMed - indexed for MEDLINE]
8.

Divalproex sodium treatment of women with borderline personality disorder and bipolar II disorder: a double-blind placebo-controlled pilot study.

Frankenburg FR, Zanarini MC.

J Clin Psychiatry. 2002 May;63(5):442-6.

PMID:
12019669
[PubMed - indexed for MEDLINE]
9.

Naltrexone in the treatment of dissociative symptoms in patients with borderline personality disorder: an open-label trial.

Bohus MJ, Landwehrmeyer GB, Stiglmayr CE, Limberger MF, Böhme R, Schmahl CG.

J Clin Psychiatry. 1999 Sep;60(9):598-603.

PMID:
10520978
[PubMed - indexed for MEDLINE]
10.

Efficacy of phenelzine and haloperidol in borderline personality disorder.

Soloff PH, Cornelius J, George A, Nathan S, Perel JM, Ulrich RF.

Arch Gen Psychiatry. 1993 May;50(5):377-85.

PMID:
8489326
[PubMed - indexed for MEDLINE]
11.

Low-dose clozapine in acute and continuation treatment of severe borderline personality disorder.

Benedetti F, Sforzini L, Colombo C, Maffei C, Smeraldi E.

J Clin Psychiatry. 1998 Mar;59(3):103-7.

PMID:
9541151
[PubMed - indexed for MEDLINE]
12.

A preliminary, randomized trial of fluoxetine, olanzapine, and the olanzapine-fluoxetine combination in women with borderline personality disorder.

Zanarini MC, Frankenburg FR, Parachini EA.

J Clin Psychiatry. 2004 Jul;65(7):903-7.

PMID:
15291677
[PubMed - indexed for MEDLINE]
13.

Evaluating three treatments for borderline personality disorder: a multiwave study.

Clarkin JF, Levy KN, Lenzenweger MF, Kernberg OF.

Am J Psychiatry. 2007 Jun;164(6):922-8.

PMID:
17541052
[PubMed - indexed for MEDLINE]
14.

[Symptoms of DSM IV borderline personality disorder in a nonclinical population of adolescents: study of a series of 35 patients].

Chabrol H, Chouicha K, Montovany A, Callahan S.

Encephale. 2001 Mar-Apr;27(2):120-7. French.

PMID:
11407263
[PubMed - indexed for MEDLINE]
15.

Olanzapine safety and efficacy in patients with borderline personality disorder and comorbid dysthymia.

Schulz SC, Camlin KL, Berry SA, Jesberger JA.

Biol Psychiatry. 1999 Nov 15;46(10):1429-35.

PMID:
10578457
[PubMed - indexed for MEDLINE]
16.

Efficacy of quetiapine for impulsivity and affective symptoms in borderline personality disorder.

Van den Eynde F, Senturk V, Naudts K, Vogels C, Bernagie K, Thas O, van Heeringen C, Audenaert K.

J Clin Psychopharmacol. 2008 Apr;28(2):147-55. doi: 10.1097/JCP.0b013e318166c4bf.

PMID:
18344724
[PubMed - indexed for MEDLINE]
17.

Relationship between borderline personality disorder and Axis I diagnosis in severity of depression and anxiety.

Comtois KA, Cowley DS, Dunner DL, Roy-Byrne PP.

J Clin Psychiatry. 1999 Nov;60(11):752-8.

PMID:
10584763
[PubMed - indexed for MEDLINE]
18.

Treatment of borderline personality disorder with risperidone.

Rocca P, Marchiaro L, Cocuzza E, Bogetto F.

J Clin Psychiatry. 2002 Mar;63(3):241-4.

PMID:
11926724
[PubMed - indexed for MEDLINE]
19.

[Antipsychotics in bipolar disorders].

Vacheron-Trystram MN, Braitman A, Cheref S, Auffray L.

Encephale. 2004 Sep-Oct;30(5):417-24. Review. French.

PMID:
15627046
[PubMed - indexed for MEDLINE]
20.

Efficacy and tolerability of pharmacotherapies for borderline personality disorder.

Bellino S, Paradiso E, Bogetto F.

CNS Drugs. 2008;22(8):671-92. Review.

PMID:
18601305
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk